Falling rates, rising deaths: the burden of venomous animal contact in sub-Saharan Africa, 1990 to 2023, and the distance to the WHO 2030 target
Although age-standardized mortality from venomous animal contact in sub-Saharan Africa declined by 28.9% between 1990 and 2023, total deaths rose by 54.8% due to population growth and a recent stagnation in progress, indicating that the region will miss the WHO 2030 target by a wide margin unless antivenom access and health-system reach expand more rapidly.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Imagine the world as a giant, bustling marketplace where diseases are like invisible vendors trying to sell their wares. Some vendors, like the flu or heart disease, are loud and well-known, but others are quiet, forgotten sellers who only show up in specific neighborhoods. One of these forgotten vendors is "snakebite envenoming"—a fancy term for getting bitten by a venomous animal, mostly snakes, and getting sick from the poison. For a long time, the big health organizations in the world have been trying to kick this vendor out of the market entirely. They set a goal: by the year 2030, they want to cut the number of people dying from these bites in half.
To see if they are winning this battle, scientists use a massive, global scoreboard called the "Global Burden of Disease" (GBD). Think of this scoreboard as a super-advanced calculator that tracks how many people get sick, how many die, and how much time they lose to illness across every country on Earth. But here's the tricky part: sometimes the scoreboard can be a bit confusing. If you have a huge crowd of people, the rate of sickness might go down (meaning fewer people get sick per person), but the total number of sick people might still go up because the crowd got so big. This paper dives into that scoreboard to figure out what's really happening in a specific, very crowded neighborhood of the world: Sub-Saharan Africa.
The Great Snakebite Paradox: Fewer Bites Per Person, But More Total Victims
This study is like a detective story that looks at the scoreboard for Sub-Saharan Africa from 1990 all the way to 2023. The researchers wanted to know: Are we winning the fight against snakebites, or are we losing ground?
The answer is a bit of a head-scratcher, a bit like watching a leaky bucket in a rainstorm. The scientists found that the rate of deaths (the number of deaths per 100,000 people) actually went down. It dropped by about 29%, falling from 3.75 deaths per 100,000 people in 1990 to 2.67 in 2023. That sounds like good news, right? It means that, statistically, the average person is safer than they used to be.
But here is the twist: Even though the rate went down, the total number of deaths skyrocketed. The number of people dying from venomous animal contact jumped by 55%, rising from 15,170 deaths in 1990 to 23,478 in 2023.
Why did this happen? The researchers used a special math trick called "decomposition" to break the problem down into three pieces, like separating a smoothie into its fruit, milk, and ice. They looked at:
- Population Growth: Did the crowd get bigger?
- Aging: Did the crowd get older (since older people often get sicker)?
- Epidemiological Change: Did the actual danger of the bites get better or worse?
The result was surprising. The "aging" piece was almost zero. The population in Sub-Saharan Africa is still very young, so getting older wasn't the reason for more deaths. The "epidemiological" piece (the actual improvement in safety) was actually doing a great job—it prevented nearly 10,000 deaths! However, the "population growth" piece was a giant. The population exploded, adding enough new people to cause nearly 18,000 extra deaths on its own.
So, the story is this: The safety measures (like better access to antivenom medicine) were working and saving lives, but the crowd of people grew so fast that the safety measures couldn't keep up. It's like having a fire truck that gets faster every year, but the city keeps building new houses so fast that the fire truck can't reach everyone in time.
The Race Against the 2030 Goal
The World Health Organization (WHO) set a target: cut the death rate in half by 2030, using 2010 as the starting line. The researchers looked at the current speed of the race and did some math to see if the region can make it.
They found that the race has stalled. Between 1995 and 2018, the death rate was dropping steadily, like a car slowing down for a turn. But since 2018, the car has hit the brakes. The rate of improvement has flattened out, dropping by almost nothing in the last five years.
If the region keeps driving at this current, stalled speed, they will miss the 2030 target by a huge margin. The researchers project that by 2030, the death rate will be 2.37 per 100,000 people. To hit the target of 1.48, they would need to suddenly speed up and improve their safety measures by about 8% every single year for the next seven years. That is roughly seven times faster than they have been improving over the last two decades.
Who is Suffering the Most?
The study also looked at who is getting hit the hardest. It turns out that the burden of snakebites is not shared equally. The poorest countries are carrying the heaviest load. The researchers found a clear line: the poorer the country, the more people die from snakebites.
However, there are some weird outliers. Some countries are doing much worse than their money would suggest. For example, South Sudan has a death rate that is roughly five times higher than the regional average, and Kenya is doing worse than Somalia, even though Kenya is much richer. This suggests that it's not just about being poor; it's about whether the life-saving medicine (antivenom) can actually reach the people who need it. In some places, the medicine exists, but it's stuck in a warehouse or too expensive for a farmer to buy.
The Bottom Line
This paper tells us that Sub-Saharan Africa is in a tough spot. They have made real progress in making snakebites less deadly per person, but they haven't scaled up their efforts fast enough to match their exploding population. The "stall" in progress since 2018 is a warning sign.
The authors are clear: this isn't a problem that can't be solved. It's not because the population is getting older or because the snakes are getting more venomous. It's simply a problem of scale. If the region can expand its access to antivenom and health care faster than its population grows, it can still save the day. But if they keep driving at the current speed, the 2030 goal will remain just out of reach. The message is clear: the safety net is there, but it needs to be stretched wider, and faster, to catch everyone.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.